Intermediate-acting insulin used to control blood sugar in diabetes. Onset in 90 minutes, lasts up to 24 hours. Cloudy appearance with peak effect at 6-8 hours. Available in human and pig insulin versions
Semaglutide reduces fasting and postprandial blood glucose levels. Improves pancreatic beta cell function and insulin secretion. Decreases glucagon concentrations and gastric emptying. Causes 3 times greater fat tissue loss than muscle tissue loss
Peripheral neuropathy refers to nerve damage affecting sensation, movement, and organ function. Can be acute (sudden onset) or chronic (slow progression). Affects motor, sensory, or autonomic nerve fibers simultaneously
Necrosis is tissue death due to insufficient blood flow. Types include coagulative, liquefactive, caseous, fat, fibrinoid, and gangrenous necrosis. Each type has distinct appearance and patterns
Mounjaro (tirzepatide) is FDA-approved for type 2 diabetes treatment. Works by helping pancreas release more insulin and slowing food digestion. Available as weekly subcutaneous injections in 2.5-15 mg strengths
Ozempic pens contain 4 weekly doses of 0.5 mg, 1 mg, or 2 mg weekly. Each pen lasts for one month and comes in 3 different strengths. Starting dose is 0.25 mg weekly for first 4 weeks